CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-05 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −10,320 | $144.75 | $1.5M | 204,254 |
| 2025-03-05 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −900 | $145.42 | $131K | 203,354 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −50 | $155.81 | $8K | 263,439 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −200 | $157.80 | $32K | 263,239 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −580 | $159.24 | $92K | 262,659 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −1,280 | $161.04 | $206K | 261,379 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −590 | $162.06 | $96K | 260,789 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −64 | $155.66 | $10K | 44,718 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −296 | $158.77 | $47K | 44,422 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −704 | $160.76 | $113K | 43,718 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −336 | $161.58 | $54K | 43,382 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $162.64 | $16K | 43,282 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −72 | $155.66 | $11K | 44,710 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −292 | $158.88 | $46K | 44,418 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −744 | $160.85 | $120K | 43,674 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −296 | $161.64 | $48K | 43,378 |
| 2025-02-26 | Sheena Jonathan Director | Sale 10b5-1 | −96 | $162.64 | $16K | 43,282 |
| 2025-02-06 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,632 | $177.77 | $290K | 149,768 |
| 2025-02-06 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −663 | $177.77 | $118K | 156,044 |
| 2025-02-05 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award 10b5-1 | +1,675 | 149,878 |
Page 54 of 55 · 1,093 trades